01 1Curia
01 1VECURONIUM BROMIDE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-01
Pay. Date : 2023-02-27
DMF Number : 12063
Submission : 1996-07-26
Status : Active
Type : II
20
Curia Italy Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is VECURONIUM BROMIDE, with a corresponding US DMF Number 12063.
Remarkably, this DMF maintains an Active status since its submission on July 26, 1996, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 01, 2023, and payment made on February 27, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
